---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-25-000069"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:33:46.440065+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Exagen Q3 revenue $17.2M (+38% YoY), record; net loss $7.1M; guides FY rev $65-70M

## Summary
- Revenue $17.2M up 38% YoY; net loss $7.1M vs $5.0M loss last year.
- Adjusted EBITDA loss narrowed to $1.9M from $4.0M; gross margin improved to 58.4%.
- AVISE CTD test volume up 16% YoY; ASP $441 (+$37 YoY).
- Cash at $35.7M, up from $30.0M in Q2 2025.
- FY2025 revenue guidance $65-70M; expects positive adjusted EBITDA in Q4 at high end.

## SEC filing metadata
- accession: 0001274737-25-000069
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000069/0001274737-25-000069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000069/exdx-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-25-000069
- JSON: https://secwatch.observer/filing/0001274737-25-000069.json
- Plain text: https://secwatch.observer/filing/0001274737-25-000069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.